Post by
askretka on Jul 11, 2023 9:35am
Another off shelf CAR-T had durability problems
Not sure if this was posted here yet?
https://www.biopharmadive.com/news/nkarta-acute-myeloid-leukemia-nk-cell-results/654083/
Cheers!!!!!!!!!!!!!!!!!!!!!!!!!!
Comment by
Noteable on Jul 11, 2023 12:05pm
NKarta Bioscience's CEO Paul Hastings' incompetence is further witnessed by his former leadership of QLT Inc. https://www.linkedin.com/in/paul-hastings-25365a6/details/experience/
Comment by
Noteable on Jul 11, 2023 12:22pm
NKarta Bioscience's CEO Paul Hastings lack luster tenure at the company has taken NKarta's stock price from US$62.00 in 2021 to US$2.00 today.